- Home
- BWFG vs VNDA Comparison
BWFG vs VNDA Comparison
Compare BWFG & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWFG
- VNDA
- Stock Information
- Founded
- BWFG 2002
- VNDA 2002
- Country
- BWFG United States
- VNDA United States
- Employees
- BWFG N/A
- VNDA N/A
- Industry
- BWFG Major Banks
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- BWFG Finance
- VNDA Health Care
- Exchange
- BWFG Nasdaq
- VNDA Nasdaq
- Market Cap
- BWFG 230.4M
- VNDA 237.9M
- IPO Year
- BWFG N/A
- VNDA 2006
- Fundamental
- Price
- BWFG $29.30
- VNDA $4.33
- Analyst Decision
- BWFG Buy
- VNDA Strong Buy
- Analyst Count
- BWFG 1
- VNDA 2
- Target Price
- BWFG $40.00
- VNDA $16.50
- AVG Volume (30 Days)
- BWFG 15.1K
- VNDA 754.6K
- Earning Date
- BWFG 04-23-2025
- VNDA 05-07-2025
- Dividend Yield
- BWFG 2.71%
- VNDA N/A
- EPS Growth
- BWFG N/A
- VNDA N/A
- EPS
- BWFG 1.23
- VNDA N/A
- Revenue
- BWFG $64,379,999.00
- VNDA $198,772,000.00
- Revenue This Year
- BWFG $58.05
- VNDA $14.36
- Revenue Next Year
- BWFG $12.43
- VNDA $44.53
- P/E Ratio
- BWFG $23.82
- VNDA N/A
- Revenue Growth
- BWFG N/A
- VNDA 3.18
- 52 Week Low
- BWFG $22.70
- VNDA $3.85
- 52 Week High
- BWFG $35.25
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- BWFG 49.62
- VNDA 43.42
- Support Level
- BWFG $28.43
- VNDA $4.27
- Resistance Level
- BWFG $30.80
- VNDA $4.46
- Average True Range (ATR)
- BWFG 1.29
- VNDA 0.22
- MACD
- BWFG 0.04
- VNDA 0.01
- Stochastic Oscillator
- BWFG 65.39
- VNDA 54.55
About BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.